Five Minutes in Healthcare is where I discuss current events with some of the industry's most influential leaders, as well as innovative thinkers who are working to meet the challenges of the novel coronavirus.

In this installment, I check in with Paul Crowe, CEO of NuView Life Sciences, about the three unique applications his company is developing to support cancer care. Using a proprietary binary test, the company can target cancer cells via in vitro laboratory assays to detect cancer, or in vivo PET scans for tumor localization, and potentially treat cancer with a theranostic capability.

We hope you enjoy the conversation. Please tell us what you think, and let us know who you would like to see interviewed next: